PONESIMOD Drug Record

  • PONESIMOD chembl:CHEMBL1096146

    Alternate Names:

    ACT-128800
    PONESIMOD

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antiinflammatory agent,for treatment of multiple sclerosis
    (1 More Sources)

    Publications:

  • PONESIMOD   S1PR1

    Interaction Score: 9.27

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name ponesimod
    Novel drug target Established target
    Mechanism of Interaction Sphingosine 1-phosphate receptor Edg-1 agonist

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions TTD

  • TdgClinicalTrial: PONESIMOD

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiinflammatory agent,for treatment of multiple sclerosis
    Drug Class small molecule
    FDA Approval not approved

    Publications:

  • TTD: Ponesimod

    • Version: 2020.06.01

    Alternate Names:
    D0Y4SI TTD Drug ID

    Drug Info:

    Publications:

  • TTD: ACT-128800

    • Version: 2020.06.01

    Alternate Names:
    D06RLU TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1096146

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL1096146

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: